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Abstract 
 The Tel-Aviv Stock Exchange (TASE) initiated an equity research 
program in 2016 dedicated to the technology sector. The main goal of the 
program was to draw more investor attention to Israeli tech firms. Today, 
nearly all equity research is performed by stock brokers, investment banks, 
and other entities which have a financial interest in the market. On the other 
hand, independent equity research is a boutique service offered by only a few 
firms worldwide. The aim of such research is to provide an unbiased opinion 
on the state of a company, including its share price and potential forthcoming 
changes. We conducted a study to explore events, such as initiation analysis 
report publications, as the release of new information to market participants. 
We hope to contribute to the growing literature on the effect of analyst reports 
on investor activities. Our findings indicate a broad market reaction to equity 
research reports published in TASE during 2017-2018.  
 
Keywords: Attention, inefficient market; Corporate News; Event Study; 
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1. Introduction 
In 2016, TASE initiated an equity research program dedicated to the 
technology sector. The main goal of the program was to draw more investor 
attention to Israeli tech firms. This research was led by two firms: Edison 
(www.edisonequityresearch.com) and the consultancy and global research 
firm, Frost & Sullivan (www.frost.com).  
Nearly all equity research is nowadays performed by stock brokers, 
investment banks, and other entities which have a financial interest in the 
market. On the other hand, independent equity research is a boutique service 
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offered by only a few firms worldwide. The aim of such research is to provide 
an unbiased opinion on the state of a company, including its share price and 
potential forthcoming changes. The analysis does not constitute investment 
advice, and analysts are prohibited from trading any securities being analyzed. 
Furthermore, companies (like Frost & Sullivan) that offer these services are 
contracted by a third party entity, such as TASE, and not the company directly. 
Compensation is received up front to further secure independent coverage. 
Within the framework of TASE’s ongoing program, Edison and Frost & 
Sullivan produce equity research reports on technology and biomedical 
companies that are listed on TASE. The firms also disseminate these reports 
online via message boards and leading business media channels. The goals of 
the program are to enhance global awareness of these companies in focus, and 
to encourage more informed investment decisions. Terms of the program are 
governed by TASE and by the Israeli Securities Agency (ISA). 
 
2. Literature overview  
Sell-side analysis has existed for years. However, the difference between 
sell-side and equity research lies in the interests of the analysts. Sell-side 
analysts often do not charge fees from the firms, but offer the firms other 
services, such as underwriting for their future capital raising. On the other 
hand, equity research firms charge a fixed fee, unrelated to the research 
outcome. The latter approach results in a less biased analysis. 
The value of sell-side equity research is a source of ongoing debate among 
academics, investment professionals, regulators, and the financial media. On 
the one hand, studies consistently demonstrate that earnings forecasts, target 
prices, investment recommendations, and narrative commentaries contain 
information for investors (Womack 1996; Givoly and Lakonishok 1979; Lys 
and Sohn 1990; Brav and Lehavy 2003; Asquith et al. 2005; Call, Chen, Tong 
2013 and Min 2016). Nevertheless, a large body of evidence suggests that the 
social context in which analysts operate renders their research biased, 
incomplete, excessively dependent on management, reliant on the past 
repeating itself, and lacking in scientific method (Abarbenall and Bernard, 
1992; Fogarty and Rogers, 2005; Kothari et al., 2009). Fogarty and Rogers 
(2005) conjecture that rather than reflecting a neutral and stable expertise that 
is unaffected by social context, analysts’ work is more accurately 
characterized by an institutionalized structure where their independence is 
compromised by financial conflicts of interest and excessive reliance on 
management as a source of firm-specific information, and where as a 
consequence, symbolic displays substitute rigorous scientific analysis. 
Consistent with institutional theory, Fogarty and Rogers (2005) find that 
analyst research is uncritical of management and naïve in the view that past 
outcomes hold the clues to predicting the future. Asquith et al. (2005) and 
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Huang et al. (2012) confirm that the average analyst report contains little 
negative commentary about firms or management. Further, Kothari et al. 
(2009) find no significant association between the content of analyst research 
and firms` cost of capital, which they attribute to credibility and timeliness 
problems with sell-side research. Collectively, these findings echo doubts 
expressed by the media, investment professionals, and regulators over the 
rigor and objectivity of analysts’ work, supported by insights from psychology 
that stress the conditional nature of individuals’ attributional search processes 
(e.g., Lau and Russell, 1980). 
Despite robust evidence for the conditional nature of attributional search, 
studies examining the properties of analyst commentaries typically adopt a 
random sampling approach designed to maximize generalizability (e.g., 
Asquith et al., 2005; Fogarty and Rogers, 2005). However, since a high 
fraction of analyst research is released in response to either good news or 
existing information (e.g., Asquith et al., 2005), failure to account for the 
incentives for attributional search can tilt the evidence in favor of observing 
bland, management-friendly research that lacks scientific rigor. Examples 
include: Financial Times, “Shoot All the Analysts”, March 20, 2001, page 22; 
Wall Street Journal, “Outlook for Analysts: Skepticism and Blame”, June 13, 
2001; Financial Times, “Titans who were brought to book”, March 11, 2008; 
Financial Times, “Investment research fights to prove its worth”, March 19, 
2009; Financial Times, “Sell-side research hit by quality controls”, June 19, 
2009.  
 
3. Research method 
This paper uses an event-study approach (ESA), which is an effective tool 
for assessing the information content of events, as perceived by market 
participants, as well as shedding light on the issue of market efficiency or 
inefficiency (Campbell et al. 2012). The underlying idea in common event 
studies is to track the market prices of securities whose issuing firms were 
involved in the studied event, in order to detect market-related reactions. The 
prices are tracked over a period that is potentially relevant for evaluating the 
effect of the event on the prices of the traded securities; this period is termed 
the event window (cf. Kliger and Gurevich, 2014, chapter 3). 
Commonly, the market reaction to the studied events has an intuitively 
predictable direction. That is, in events consisting of good news, the market 
participants are expected to react positively, thereby raising the security prices 
of the firms undergoing the studied event. Conversely, in bad-news events, the 
market participants are expected to react negatively, and the security prices 
are expected to fall.  
In our event-study model, we present the estimated cumulative average 
abnormal return (CAAR) over a period of time t to t+x, and the estimated 
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average abnormal return (AAR) at time t. The CAAR is calculated based on a 
basic naïve benchmark model assuming the normal return for all stocks to be 
the market return as represented by a broad stock market index, such as the 
S&P 500 and the healthcare index representing the whole pharmaceutical 
industry. In effect, the naïve benchmark regards anything different from the 
average market behavior as abnormal. It is termed naïve because it ignores 
basic economic assumptions, such as allowing riskier stocks to command 
higher expected returns due to investors’ risk aversion. This single-factor 
benchmark assumes linear relations between stock and market-index returns, 
and includes the parameters 𝛼𝛼𝑖𝑖 and 𝛽𝛽𝑖𝑖, which are usually estimated by a linear 
regression with the stock return as the response variable and the market return 
as the predictor variable. To obtain estimates that are not affected by the 
studied event, the data range for the regression must be chosen in a way that 
minimizes the possible influence of the event; that is, the range should not 
belong to the event window. The rationale for this range is to estimate 
parameters that are representative of the stock but are unaffected by the event, 
so they enable estimation of the “normal” stock return, which in turn enables 
detecting irregularities or “abnormal” returns. 
 
4. Testable hypotheses for the equity research program effect 
Hypothesis 1, pre equity research (ER) publication: Pre-event attention: 
upcoming ER publication ignites a period of investor attention to the stocks 
covered in the program, thereby causing: (i) an upward trend in cumulative 
abnormal returns and (ii) increased trading activity, manifested by positive 
abnormal trading volume.  
Hypothesis 2, post ER publication: Post-event attention: in the period 
following ER publication, we observe a decrease in investor attention to the 
stocks covered in the program, thereby causing: (i) a downward trend in 
cumulative abnormal returns and (ii) decreased trading activity, manifested by 
positive abnormal trading volume.  
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5. Data and analysis 
5.1 Data 
The data consist of all 20 firms entered into the equity research analysis 
program with TASE as shown in  table 1 below: 
Table 1: List of 20 traded TASE firms participating in the equity research program and date 
of initiation report: 
No` Company Date of Initiation Report 
1 Allium Medical Solutions (ALMD) 11/2/16 
2 BioLight Life Sciences (BOLT) 19/10/16 
3 Clal Biotechnology Industries (CBI) 15/1/18 
4 CollPlant Holdings (CLGN) 3/9/17 
5 Ellomay Capital (ELLO) 28/9/16 
6 Foresight Autonomous Holdings (FRST) 27/9/16 
7 Intec Pharma (NTEC) 29/09/16 
8 Nano Dimension (NNDM) 9/12/16 
9 Pluristem Therapeutics (PSTI) 23/11/16 
10 Pointer Telecom (PNTR) 11/8/16 
11 BiolineRX Ltd. (BLRX) 20/7/17 
12 Brainsway Ltd. (BRIN) 6/8/17 
13 D.N.A. Biomedical Solutions (DNA) 10/10/17 
14 Oramed Pharmaceuticals Inc. (ORMD) 23/12/17 
15 Redhill Biopharma Ltd. (RDHL) 12/7/17 
16 Energix Renewable Energies Ltd. (ENRG) 25/6/17 
17 Enlight Renewable Energy Ltd. (ENLT) 28/1/18 
18 Safe-T Group Ltd. (SAFT) 2/7/18 
19 Vonetize PLC (VNTZ) 2/10/17 
20 Kadimastem (KDMS) 12/6/18 
 
We gathered all prices and volume data from www.tase.co.il. All sector 
data was also extracted from the same website. 
 
5.2 Analysis 
Table 1 plots CAARs around initiation report publication. At the pre-
publication period there is no market reaction. On the day of publication 
CAAR is 1.97% (t-stat, 2.20) and ten trading days post publication we see a 
robust and significant effect of the initiation analysis report at6.44% (t-stat, 
2.39). We see a downward effect after 30 days post initiation report 
publication. 
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Table 2: CAARs and abnormal daily price statistics around initiation analysis report 
publication, for -50 to + 50 days 
Days 
relative to 
event 
Equity research firms 
CAAR, % t-statistic 
-50 to -1 0.41% 0.06 
-40 to 1 -0.59% -0.10 
-30 to 1 -1.88% -0.38 
-10 to 1 -0.58% -0.20 
-2 0.31% 0.34 
-1 -0.68% -0.75 
0 1.97% 2.20 
1 1.17% 1.31 
2 0.51% 0.57 
3 0.24% 0.27 
0 to 10 6.44% 2.39 
0 to 20 4.77% 1.22 
2 to 30 0.16% 0.03 
2 to 40 -5.53% -0.99 
2 to 50 -5.10% -0.81 
 
Figure 1: CAARs and abnormal daily volume statistics around initiation analysis report 
publication, for -50 to + 50 days 
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Table 3: CAARs and abnormal daily volume statistics around initiation analysis report 
publication, for + 20 days versus market sector (TASE technology sector) 
 
Discussion and conclusion 
 Our findings indicate a broad market reaction to equity research analysis 
reports published in TASE during 2017-2018. These findings support other 
studies (e.g., Asquith et al., 2005) showing that a high fraction of analyst 
research is released in response to either good news or no material new 
information. We find that although the market anticipates and is aware of 
future publication, we still witness a robust market reaction. We postulate that 
this market reaction is due to the nature of the firms under scrutiny, as all these 
firms are small-cap firms (under $5bn market cap); thus, they can be viewed 
as ‘under-the-radar’ firms. Namely, new information provided in equity 
research reports creates new hype, thus we see share price as well as volume 
increase.    
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